Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,586,212
  • Shares Outstanding, K 541,546
  • Annual Sales, $ 11,501 M
  • Annual Income, $ 16,800 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.45
  • Price/Sales 0.73
  • Price/Cash Flow 1.90
  • Price/Book 0.68
  • Price/Earnings ttm 3.29
  • Earnings Per Share ttm 4.73
  • Most Recent Earnings $0.36 on 11/06/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.060 on 06/27/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.35
  • Number of Estimates 6
  • High Estimate 1.50
  • Low Estimate 1.25
  • Prior Year 1.40
  • Growth Rate Est. (year over year) -3.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.00 +13.24%
on 10/29/20
16.15 -1.83%
on 11/16/20
+0.14 (+0.92%)
since 10/16/20
3-Month
14.00 +13.24%
on 10/29/20
17.03 -6.90%
on 08/19/20
-0.34 (-2.07%)
since 08/14/20
52-Week
12.75 +24.35%
on 03/16/20
23.11 -31.39%
on 02/06/20
-1.85 (-10.42%)
since 11/15/19

Most Recent Stories

More News
WWE® Elects Michelle McKenna & JoEllen Lyons Dillon to Board of Directors

WWE ® (NYSE: WWE) today announced that Michelle McKenna and JoEllen Lyons Dillon have been elected to its Board of Directors.

RNG : 36.74 (-3.16%)
NSP : 75.51 (-2.64%)
VRTS : 241.53 (+1.21%)
MYL : 15.86 (+1.96%)
DM : 4.58 (+17.14%)
WWE : 100.65 (+2.65%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS...

MYL : 15.86 (+1.96%)
VTRS : 12.62 (-2.92%)
FDA allows automatic 'generic' swap for brand-name insulin

U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore.

MYL : 15.86 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Mylan, Inc. was incorporated in Pennsylvania in 1970. The Company and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients ('API')....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 16.59
1st Resistance Point 16.22
Last Price 15.86
1st Support Level 15.41
2nd Support Level 14.97
3rd Support Level N/A

See More

52-Week High 23.11
Fibonacci 61.8% 19.15
Fibonacci 50% 17.93
Fibonacci 38.2% 16.71
Last Price 15.86
52-Week Low 12.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar